The FDA has approved the Shield test, a first-of-its-kind blood test for colon cancer, which is noninvasive and can detect tumors and precancerous growths, and is expected to increase coverage by private and government insurance.
The FDA has approved the Shield test, a first-of-its-kind blood test for colon cancer, which is noninvasive and can detect tumors and precancerous growths, and is expected to increase coverage by private and government insurance.
Get the best of The Community Voice directly in your email inbox.
Sending to:
